Neil Woodhouse1, Howard Mellor2, Jose Ulloa1, Guy Healing2, Jason Kirk2, Paul Hockings3
1PHB Imaging, AstraZeneca, Alderley Edge, Cheshire, United Kingdom; 2GSA, AstraZeneca, Alderley Edge, Cheshire, United Kingdom; 3PHB Imaging, AstraZeneca, Molndal, Gothenburg, Sweden
Doxorubicin induced cardiotoxicity was examined in two groups of male Han-Wistar rats (n = 6/group), Vehicle (0.9 % saline) and Dox (doxorubicin 1.25 mg/kg) using a retrospectively gated IntraGate FLASH multi-slice cine sequence at 4.7T. Gadopentetate was administered as an intravenous bolus to three rats per group. Significant differences in end systolic volume, stroke volume, ejection fraction, and fractional shortening were demonstrated between the Vehicle and Dox groups. There were statistically significant (p=0.001) differences in late gadolinium enhancement after gadopentetate infusion.